Zdrowie i gospodarka · 29/05/2014

FDA Releases Draft Guidance on Best Practices for Proprietary Drug Names

The Food and Drug Administration (FDA) has made available a draft guidance document outlining best practices for developing proprietary names for prescription and nonprescription human drugs and biological products, with the aim of preventing medication errors and misbranding.